Explained: Why RNA vaccines for Covid-19 raced to the front of the pack
Many years of research have enabled scientists to quickly synthesize RNA vaccines and deliver them inside cells.
Many years of research have enabled scientists to quickly synthesize RNA vaccines and deliver them inside cells.
The discovery can help to cure bacterial infections without inducing resistance or causing harm to good bacteria.
M-CELS are purpose-driven living systems with multiple interacting living components.
MIT researchers identify a molecule that could target advanced prostate cancer as well as a variety of other cancers.
Immuneering uses bioinformatics to develop new medicines while also helping large pharmaceutical companies improve their treatments.
Biological engineer discusses condensing the time taken to develop therapeutics down from many years to a matter of months.
New technology cuts cell culture time by half and uses more targeted cell sorting and purification methods.
The experimental drug has shown promise in early-stage clinical trials conducted in Singapore.
The company is developing treatments that restore gut bacteria in people struggling with a range of diseases.
Certain cancer therapeutics concentrate within cells — a finding that could change the way scientists think about drug design.
Computational modeling yields a protein fragment that could bind to coronavirus spike proteins and destroy them.
MIT researchers pinpoint mechanism and demonstrate that drugs could help.
Automated tabletop machine could accelerate the development of novel drugs to treat cancer and other diseases.
Study: Vaccines find more success in development than any other kind of drug, but have been relatively neglected in recent decades.
Report offers guidelines to help prevent viruses from tainting biopharmaceutical drugs.